The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan

The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan

ObjectiveAs a standard therapy, tyrosine kinase inhibitors (TKIs) improved survival in patients with non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) mutation. However, treatment-related cardiotoxicity, particularly arrhythmia, cannot be ignored. With the prevalence of...

Full description

Bibliographic Details
Main Authors: Wei-Ting Chang, Hui-Wen Lin, Ting-Chia Chang, Sheng-Hsiang Lin, Yi-Heng Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
NSCLC
tyrosine kinase inhibitors
platinum analogues
death
arrhythmia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1172036/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1172036/full

Similar Items